CHERISH Events

Conference Roundup: #AHSR2024

A curated list of appearances featuring CHERISH researchers and colleagues.

October 16-18, 2024

Addiction Health Services Research (AHSR) Conference 2024, San Francisco, CA

TheΒ Addiction Health Services Research (AHSR) Conference, held since 2005, annually brings together researchers, policymakers, and treatment providers to focus on how systems redesign can effectively and sustainably be implemented.

Connect with CHERISH researchers and colleagues in the field of substance use, HIV, and HCV research. View the full program here.

Wednesday, October 16th

8:30 a.m. – 10:00 a.m.

Pre-conference Workshops

  • Implementation Costing and Budget Impact Analysis: An introduction and Application for Research and Practice, πŸ“ Marina
    • Bryan R. Garner, PhD, The Ohio State University, CHERISH Research Affiliate, co-presenter
    • Andrea Eisman, Wayne State University, CHERISH Research Affiliate, co-presenter
    • Sean M. Murphy, PhD, Weill Cornell Medicine, CHERISH Methodology Core Co-director, co-presenter
    • Danielle Ryan, MPH, Weill Cornell Medicine, co-presenter

10:30 a.m. – 12:00 p.m.

Pre-conference Workshops

  • Using Population Claims Data in Substance Use Research: Focus on the T-MSIS Analytic File, πŸ“ Marina
    • Yuhua Bao, Weill Cornell Medicine, CHERISH investigator, co-presenter
    • Shashi Kapadia, Weill Cornell Medicine, CHERISH Research Affiliate, co-presenter
    • Jake R. Morgan, Boston University School of Public Health, CHERISH investigator, co-presenter
  • Part II. Pragmatic Implementation Science: Tools You Can Use to Enhance the Impact of Your Research, πŸ“ Presidio
    • Bryan R. Garner, PhD, The Ohio State University, CHERISH Research Affiliate, co-presenter
    • Helene Chokron Garneau, PhD, MPH, Stanford University School of Medicine, co-presenter
    • Karen Seal, MD, San Francisco Veterans Affairs Health Care System, co-presenter
    • Lindsey Zimmerman, PhD, National Center for Posttraumatic Stress Disorder, co-presenter

4:30 – 5:30 p.m.

Poster Session I, πŸ“ Twin Peaks

  • Allison Ju-Chen Hu, PhD, Weill Cornell Medicine, 2024-2025 CHERISH pilot grant recipient
    • (#16) Distribution of Opioid Analgesics to Communities of Different Racial/Ethnic and Socioeconomic Profiles, 2011-2021
    • (#30) Organizational/Community Characteristics and Medication for Opioid Use Disorder Prescribers in Federally Qualified Health Centers
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate
    • (#21) β€œIt was a cold handoff” Reentry Care Experiences During the Implementation of A State Law Requiring OUD Treatment in Jails
  • Kayla Hutchings, MPH, Weill Cornell Medicine
    • (#44) Priority Interventions for Improving Health Outcomes for People with Injection-Drug Related Interventions: A Mixed Methods Study
  • Bryan R. Garner, PhD, The Ohio State University, CHERISH Research Affiliate
    • (#58) The Dissemination, Implementation, effectiveness, Sustainment, Economic, and Level-of-scaling (DIeSEL) Research Design
  • Czarina Behrends, PhD, MPH, Weill Cornell Medicine, CHERISH Research Affiliate
    • (#60) A Methodological Approach for the Online Recruitment of a National Cohort of People Who Inject Drugs
  • Hana Zwick, Boston Medical Center
    • (#61) HEAL D2A Modeling and Economic Resource Center (MERC): Semi-Structured Interviews to Support Opioid Intervention Decision-Making
  • Jocelyn Vititow, Boston Medical Center, CHERISH staff
    • (#62) Experiences of a Community Advisory Board with Substance Use Simulation Modeling
  • Sierra Castedo De Martell, PhD, MPH, Chestnut Health Systems, 2023-2024 CHERISH pilot grant recipient
    • (#67) Estimating Quality-Adjusted Life Years from Recovery Quality of Life: Mapping the EUROHIS-QOL 8-Item Index to the EQ5D-5L and PROMIS/PROPr
  • Michael L. Dennis, PhD, Chestnut Health Systems, CHERISH Research Affiliate
    • (#79) The History and Future of Recovery Management Checkups

Thursday, October 17th

10:45 a.m. – 12:00 p.m.

Scientific Breakout Session III, Oral PresentationsΒ 

  • Todd Wagner, PhD, Stanford University, CHERISH Research Affiliate
    • Economic Evaluation of Cost to Deliver and Participate in Implementation Strategies for Expanding Medications for Opioid Use Disorder, πŸ“ Telegraph Hill
  • Kathryn McCollister, PhD, University of Miami Miller School of Medicine, CHERISH Methodology Core Director
    • Economic Impact of Recovery Management for Substance Use Disorders (SUD) in Healthcare Settings: Societal Costs of Recovery Management Checkups For Primary Care (RMC-PC), πŸ“ Telegraph Hill
  • Danielle Ryan, MPH, Weill Cornell Medicine
    • Cost Analysis of MOUD Implementation and Sustainability in Massachusetts Jails, πŸ“ Telegraph Hill
  • Dhruv Khurana, PhD, MS, MA, David Geffen School of Medicine at UCLA, CHERISH Research Affiliate
    • The Metrics of MAT: A Comprehensive Benefit-Cost Analysis Framework for Naloxone Distribution (Case of California), πŸ“ Telegraph Hill

2:45 p.m. – 4:00 p.m.

Scientific Breakout Session IV, Oral Presentations

  • Erika Crable, PhD, MPH, University of California San Diego, CHERISH Research Affiliate
    • Zooming Out Then In: State and Local-Level Causal Loop Diagram Development to Inform Data Products for Policy Actions, πŸ“ Telegraph Hill
  • Bryan R. Garner, PhD, The Ohio State University, CHERISH Research Affiliate
    • Using Facilitation and Incentivization as Enhancement Strategies for CM Implementation: Results from a 28-Site Cluster-Randomized Type 3 Hybrid Trial, πŸ“ Pacific Heights

4:15 p.m. – 5:30 p.m.

Scientific Breakout Session V, Oral Presentations

  • Bulat Idrisov, MD, MSc, University of Washington, 2023-2024 CHERISH pilot grant recipient
    • Public, Private, and Out-of-Pocket U.S. Healthcare Expenditures on Substance and Alcohol Use by Types of Care from 2010 – 2019, πŸ“ Sea Cliff

Friday, October 18th

9:30 a.m. – 10:45 a.m.

Scientific Breakout Session VI, Oral Presentations

  • Tyler Bartholomew, PhD, University of Miami Miller School of Medicine, CHERISH Research Affiliate
    • Intravenous Methamphetamine Use and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022-2023, πŸ“ Telegraph Hill
  • Sugy Choi, MS, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate
    • Exploring the Role of Toxicology Testing in Take-Home Dosing Decisions within Opioid Treatment Programs: Insights from New York State Clinics, πŸ“ Marina
  • Dhruv Khurana, PhD, MS, MA, David Geffen School of Medicine at UCLA, CHERISH Research Affiliate
    • Evaluation of California’s Wellness & Recovery Program, πŸ“ Marina

10:45 a.m. – 11:45 a.m.

Poster Session II, πŸ“ Twin Peaks

  • Sugy Choi, MS, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate
    • (#38) Exploring Patient Perspectives on Coordination of Care for Substance Use Disorder Treatment Among Pregnant and Parenting Individuals
  • Jazmine Li, MPH, Weill Cornell Medicine, CHERISH staff
    • (#44) Cost of Implementing Evidence-Based Practices to Reduce Opioid Overdose Fatalities in New York State Communities
  • Kathryn McCollister, PhD, University of Miami Miller School of Medicine, CHERISH Methodology Core Director
    • (#45) Assessing Budget Impact of HIV Prevention and Substance Use Disorder Treatment: Costs of An Adaptive Approach from a recent Sequential, Multiple Assignment, Randomized Trial
  • Rosalie Pacula, PhD, University of Southern California, CHERISH Advisory Board member
    • (#53) The Association Between State Cannabis Policies and Cannabis Use Among Adults and Youth, United States, 2002-2019
  • Cindy Thomas, PhD, Brandeis University Heller School for Social Policy and Management, CHERISH Research Affiliate
    • (#59) Medicaid Managed Care Policies for Different Buprenorphine Treatment Formulations